Hair Loss

Educational Notice

Peptidings provides information for educational and research purposes only. The peptides discussed on this page are subjects of ongoing scientific research. None of the information presented here constitutes medical advice or a recommendation for use. Consult a qualified healthcare provider before making any decisions about peptide use.

Browse by Condition

Hair Loss

Peptide research in the context of hair loss focuses primarily on mechanisms relevant to follicle biology: copper-dependent collagen and keratin synthesis, tissue repair signaling, anti-inflammatory pathways in the scalp, and actin dynamics relevant to follicle structure. The evidence base is thin. Most compounds discussed in this context have preclinical or cosmetic-use data that does not translate cleanly to claims about hair regrowth—and the distinction between topical application and systemic injection is particularly important here.

Evidence Tiers:
Approved Drug
Clinical Trials
Pilot / Human Data
Preclinical Only
It’s Complicated

Compounds with Research Relevant to Hair Loss

Each compound links to its full pillar article. The most useful sections for evaluating a specific application are the Claims vs. Evidence table and the Safety, Risks, and Limitations section. Evidence tiers reflect the strongest available data for a compound overall—not necessarily for this specific application.

Pilot Data

Acetyl Tetrapeptide-3: What the Research Actually Shows

ECM-anchoring peptide combined with biochanin A (a 5-alpha-reductase inhibitor) in the Capixyl formulation. Human data is manufacturer-sponsored and tests the combination, not the peptide alone.

Read the research →

Pilot Data

Biotinoyl Tripeptide-1: What the Research Actually Shows

Biotin-conjugated GHK peptide targeting follicle anchoring via laminin-5 and collagen IV upregulation. Clinical evidence exists only within the Procapil combination—no standalone human data.

Read the research →

Pilot Data

Copper Peptides for Hair: GHK-Cu vs AHK-Cu

GHK-Cu and AHK-Cu—copper-binding tripeptides with distinct mechanisms. GHK-Cu has topical human data from wound healing and skin contexts; hair-specific clinical evidence is limited to cosmetic-use observations.

Read the research →

Clinical Trials
WADA

IGF-1 and Hair Loss: What the Research Actually Shows

Growth factor mediating many of GH's effects on tissues including hair follicles. WADA-prohibited. Systemic administration carries hypoglycemia risk—follicle-level delivery remains an unsolved problem.

Read the research →

Clinical Trials

KGF / Palifermin: What the Research Actually Shows

FDA-approved for oral mucositis (Kepivance). FGFR2b-mediated follicle keratinocyte proliferation is well-characterized, but no clinical trials exist for hair loss specifically.

Read the research →

Pilot Data

PTD-DBM: What the Research Actually Shows

Cell-penetrating peptide targeting the Wnt/β-catenin pathway—the master switch for follicle regeneration. Published RCTs compare favorably to minoxidil 3%, but trials are small, industry-associated, and unreplicated.

Read the research →

Preclinical

Substance P and Hair Loss: What the Research Actually Shows

Neuropeptide involved in neurogenic inflammation and follicle cycling. NK1 receptor antagonism—not supplementation—is the therapeutic rationale. Human biopsy data supports the catagen-induction pathway.

Read the research →

Preclinical

Thymulin and Hair Loss: What the Research Actually Shows

Thymic nonapeptide modulating follicle immune privilege via T-cell regulation. No human hair loss trials. The thymic-follicle immune connection is mechanistically plausible but clinically unvalidated.

Read the research →

Research Cluster

The skin and cosmetic research context for these compounds is covered in the Skin and Cosmetic Peptides cluster hub.

Browse the Cluster →

Disclaimer: This page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. The compounds discussed have not been evaluated by the FDA for all applications described. Consult a qualified healthcare provider before making any decisions about your health.

Scroll to Top